Add Company
Join Now

Robert Morales Email

SVP Accounting and Finance . Ovid Therapeutics

New York, NY

Location

r*******@ovidrx.com

Primary Email

How to contact Robert Morales

Join and see Robert's contact info for free!

Email

Current Roles

Ovid Therapeutics

Employees:
46
Revenue:
$214.1M
About
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid's drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients. Review our community guidelines: http://www.ovidrx.com/community-guidelines/
Ovid Therapeutics Address
441 9th Avenue
New York, NY
United States
Ovid Therapeutics Email

Past Companies

Ovid Therapeutics Inc.Senior Vice President Accounting and Finance
Acorda Therapeutics, Inc.Vice President Finance and Controller (Principal Accounting & Financial Officer)
Acorda Therapeutics, Inc.Executive Director Finance and Controller
www.growjo.com

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.